State of the art in the treatment of laryngeal cancer

Standard

State of the art in the treatment of laryngeal cancer. / Jenckel, Friederike; Knecht, Rainald.

In: ANTICANCER RES, Vol. 33, No. 11, 01.11.2013, p. 4701-10.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Jenckel, F & Knecht, R 2013, 'State of the art in the treatment of laryngeal cancer', ANTICANCER RES, vol. 33, no. 11, pp. 4701-10.

APA

Jenckel, F., & Knecht, R. (2013). State of the art in the treatment of laryngeal cancer. ANTICANCER RES, 33(11), 4701-10.

Vancouver

Jenckel F, Knecht R. State of the art in the treatment of laryngeal cancer. ANTICANCER RES. 2013 Nov 1;33(11):4701-10.

Bibtex

@article{ce3b08540d1c470498587343b0cbdb95,
title = "State of the art in the treatment of laryngeal cancer",
abstract = "Nowadays clinics can offer patients a variety of different therapy options when laryngeal squamous cell carcinoma is diagnosed histologically. Depending on a variety of different factors, including tumor size, possible metastasis, health status and age of the patient, but also economic factors, a treatment schedule is established. Aim of every treatment decision should be organ larynx preservation and preservation of laryngeal function. The objective of this review is to give an overview of treatment modalities for laryngeal cancer, based not only on traditional but also on the latest studies regarding the treatment of this disease. Surgical approaches, as well as conservative treatment options, such as chemoradiotherapy, induction therapy and target therapy, are discussed. The optimal combination of surgical treatment and conservative treatment modalities need to be further investigated. Furthermore optimal laryngeal function as well as laryngeal preservation must be re-defined.",
keywords = "Animals, Combined Modality Therapy, Humans, Laryngeal Neoplasms, Prognosis",
author = "Friederike Jenckel and Rainald Knecht",
year = "2013",
month = nov,
day = "1",
language = "English",
volume = "33",
pages = "4701--10",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "11",

}

RIS

TY - JOUR

T1 - State of the art in the treatment of laryngeal cancer

AU - Jenckel, Friederike

AU - Knecht, Rainald

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Nowadays clinics can offer patients a variety of different therapy options when laryngeal squamous cell carcinoma is diagnosed histologically. Depending on a variety of different factors, including tumor size, possible metastasis, health status and age of the patient, but also economic factors, a treatment schedule is established. Aim of every treatment decision should be organ larynx preservation and preservation of laryngeal function. The objective of this review is to give an overview of treatment modalities for laryngeal cancer, based not only on traditional but also on the latest studies regarding the treatment of this disease. Surgical approaches, as well as conservative treatment options, such as chemoradiotherapy, induction therapy and target therapy, are discussed. The optimal combination of surgical treatment and conservative treatment modalities need to be further investigated. Furthermore optimal laryngeal function as well as laryngeal preservation must be re-defined.

AB - Nowadays clinics can offer patients a variety of different therapy options when laryngeal squamous cell carcinoma is diagnosed histologically. Depending on a variety of different factors, including tumor size, possible metastasis, health status and age of the patient, but also economic factors, a treatment schedule is established. Aim of every treatment decision should be organ larynx preservation and preservation of laryngeal function. The objective of this review is to give an overview of treatment modalities for laryngeal cancer, based not only on traditional but also on the latest studies regarding the treatment of this disease. Surgical approaches, as well as conservative treatment options, such as chemoradiotherapy, induction therapy and target therapy, are discussed. The optimal combination of surgical treatment and conservative treatment modalities need to be further investigated. Furthermore optimal laryngeal function as well as laryngeal preservation must be re-defined.

KW - Animals

KW - Combined Modality Therapy

KW - Humans

KW - Laryngeal Neoplasms

KW - Prognosis

M3 - SCORING: Journal article

C2 - 24222104

VL - 33

SP - 4701

EP - 4710

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 11

ER -